 | | DRUG: Isopropylantipyrine, ergotamine tartrate and anhydrous caffeine | |
Entry |
|
Name |
Isopropylantipyrine, ergotamine tartrate and anhydrous caffeine; Cleamine A (TN) |
Component |
Isopropylantipyrine [DR: D01380], Ergotamine tartrate [DR: D00679], Anhydrous caffeine [DR: D00528]
|
Class |
Neuropsychiatric agent
DG01964 Ergot alkaloid
DG01982 Antimigraine, ergot alkaloid
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
|
Remark |
Therapeutic category: | 1149 |
|
Efficacy |
Antimigraine |
Comment |
Ergotamine is primarily metabolized by CYP3A4.
|
Metabolism |
Enzyme: CYP3A4 [HSA: 1576]
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N02 ANALGESICS
N02C ANTIMIGRAINE PREPARATIONS
N02CA Ergot alkaloids
N02CA52 Ergotamine, combinations excl. psycholeptics
D07585 Isopropylantipyrine, ergotamine tartrate and anhydrous caffeine <JP>
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
114 Antipyretics and analgesics, anti-inflammatory agents
1149 Others
D07585 Isopropylantipyrine, ergotamine tartrate and anhydrous caffeine
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01964 Ergot alkaloid
DG01982 Antimigraine, ergot alkaloid
D07585 Isopropylantipyrine, ergotamine tartrate and anhydrous caffeine
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D07585 Isopropylantipyrine, ergotamine tartrate and anhydrous caffeine
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D07585
|
Other DBs |
|
LinkDB |
|
|
» Japanese version » Back
|